Renal cell carcinoma (RCC) with inferior vena cava (IVC) tumor thrombus remains one of the most complex and high-risk scenarios in urologic oncology. Despite advances in imaging and perioperative management, venous invasion still occurs in approximately 4–10% of cases and significantly impacts staging, prognosis, and surgical complexity.1
Radical nephrectomy with caval thrombectomy remains the only potentially curative treatment. However, the optimal surgical approach remains debated, particularly with the rapid expansion of robotic surgery. Until recently, the available evidence has been fragmented, largely limited to retrospective institutional series and lacking comprehensive comparative analyses across surgical techniques.2
The Most Comprehensive Comparative Evidence to Date
Our systematic review and network meta-analysis was designed to address this critical evidence gap. By integrating all available comparative studies and simultaneously evaluating open, laparoscopic, and robotic approaches, this study represents, to our knowledge, the most comprehensive comparative synthesis currently available on surgical management of nonmetastatic RCC with IVC tumor thrombus. The use of network meta-analysis enabled a unified comparison across surgical techniques, providing a robust framework to assess their relative perioperative outcomes and clinical applicability. This approach overcomes the limitations of prior studies and offers the most complete evidence base currently achievable in this field.
Key Findings
Our findings confirm that open surgery remains the reference standard, particularly in patients with advanced thrombus levels and complex vascular anatomy. However, robotic surgery demonstrated favorable perioperative outcomes in appropriately selected patients and experienced centers, including reduced blood loss and shorter hospitalization. Importantly, robotic approaches showed the fastest growth in scientific adoption, with an annual publication increase of +17% during the study period, reflecting a clear and accelerating shift toward robotic management. This trend underscores the increasing clinical relevance of robotic surgery and highlights the need for robust comparative evidence to guide its appropriate implementation in complex oncologic surgery.4
Implications for Surgical Practice and Future Directions
Beyond surgical technique alone, our findings reinforce that outcomes are primarily driven by surgical expertise, patient selection, and institutional experience. These procedures remain technically demanding and should be centralized in high-volume referral centers with multidisciplinary teams. By providing the most complete synthesis of available evidence to date, this study establishes a critical comparative foundation to guide surgical decision-making in this challenging clinical setting. As robotic surgery continues to expand, high-quality collaborative research and prospective data will be essential to further refine patient selection and optimize outcomes.
Written by:
- Daniele Amparore, Department of Oncology, University of Turin, Orbassano, Italy; Division of Urology, Department of Surgery, FPO-IRCCS Candiolo Cancer Institute, Candiolo, Italy
- Savio Domenico Pandolfo, Department of Urology, University of L'Aquila, L'Aquila, Italy; Department of Neurosciences and Reproductive Sciences and Odontostomatology, University of Naples Federico II, Naples, Italy
References:
- Wu Z, Zhang Z, Wang X, Wang J, Xie L, Xu H, et al. Prognostic Significance of Grade Discrepancy Between Primary Tumor and Venous Thrombus in Nonmetastatic Clear-cell Renal Cell Carcinoma: Analysis of the REMEMBER Registry and Implications for Adjuvant Therapy. Eur Urol Oncol 2024;7:112–21.PubMed https://doi.org/10.1016/j.euo.2023.06.006
- Garg H, Psutka SP, Hakimi AA, Kim HL, Mansour AM, Pruthi DK, et al. A Decade of Robotic-Assisted Radical Nephrectomy with Inferior Vena Cava Thrombectomy: A Systematic Review and Meta-Analysis of Perioperative Outcomes. J Urol 2022;208:542–60.PubMed https://doi.org/10.1097/JU.0000000000002829
- Amparore D, Pandolfo SD, Bertolo R, Erdem S, Diana P, Marandino L, Muselaers S, Palumbo C, Pavan N, Pecoraro A, Piana A, Mjaess G, Roussel E, Wu Z, Cacciamani G, Campi R, Marchioni M; European Association of Urology Young Academic Urologists Renal Cancer Working Group. Surgical Management of Nonmetastatic Renal Cell Carcinoma with Inferior Vena Cava Thrombus: A Systematic Review and Network Meta-analysis. Eur Urol Oncol. 2026 Feb 4:S2588-9311(26)00028-3. doi: 10.1016/j.euo.2026.01.007. Epub ahead of print. PMID: 41644363.
- Pandolfo SD, Marchioni M, Campi R, Amparore D; European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Working Group. YAU renal cancer spotlight: Is minimally invasive surgery the future of inferior vena cava thrombectomy? Minerva Urol Nephrol. 2024 Aug;76(4):516-518. doi: 10.23736/S2724-6051.24.05981-0. PMID: 39051896.